BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20383640)

  • 1. Treatment and outcome in muscle invasive bladder cancer: a population-based survey.
    Leliveld AM; Doornweerd BH; Bastiaannet E; Schaapveld M; de Jong IJ
    World J Urol; 2010 Aug; 28(4):439-44. PubMed ID: 20383640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer.
    Goossens-Laan CA; Leliveld AM; Verhoeven RH; Kil PJ; de Bock GH; Hulshof MC; de Jong IJ; Coebergh JW
    Int J Cancer; 2014 Aug; 135(4):905-12. PubMed ID: 24420527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume.
    Goossens-Laan CA; Visser O; Hulshof MC; Wouters MW; Bosch JL; Coebergh JW; Kil PJ
    BJU Int; 2012 Jul; 110(2):226-32. PubMed ID: 22044615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
    Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.
    Chahal R; Sundaram SK; Iddenden R; Forman DF; Weston PM; Harrison SC
    Eur Urol; 2003 Mar; 43(3):246-57. PubMed ID: 12600427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer.
    Ritch CR; Balise R; Prakash NS; Alonzo D; Almengo K; Alameddine M; Venkatramani V; Punnen S; Parekh DJ; Gonzalgo ML
    BJU Int; 2018 May; 121(5):745-751. PubMed ID: 29281848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study.
    Patel MI; Bang A; Gillatt D; Smith DP
    BJU Int; 2015 Oct; 116 Suppl 3():18-25. PubMed ID: 26334934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.
    Williams SB; Huo J; Chamie K; Hu JC; Giordano SH; Hoffman KE; Dinney CPN; Kamat AM; Shih YT
    Eur Urol Focus; 2017 Apr; 3(2-3):258-264. PubMed ID: 28753760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
    J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
    Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer.
    Martini T; Mayr R; Wehrberger C; Dechet C; Lodde M; Palermo S; Trenti E; Comploj E; Pycha A; Madersbacher S
    Int Braz J Urol; 2013; 39(5):622-30. PubMed ID: 24267105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population based assessment of perioperative mortality after cystectomy for bladder cancer.
    Isbarn H; Jeldres C; Zini L; Perrotte P; Baillargeon-Gagne S; Capitanio U; Shariat SF; Arjane P; Saad F; McCormack M; Valiquette L; Peloquin F; Duclos A; Montorsi F; Graefen M; Karakiewicz PI
    J Urol; 2009 Jul; 182(1):70-7. PubMed ID: 19447427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder sparing surgery in high-grade bladder cancer.
    Yakovlev PG; Klyushin DA; Vereshchako RI
    Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
    Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
    Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival.
    Lenis AT; Lec PM; Michel J; Brisbane W; Golla V; Sharma V; Gollapudi K; Blumberg J; Chamie K
    Urol Oncol; 2020 Oct; 38(10):796.e7-796.e14. PubMed ID: 32446641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy.
    D'Rummo KA; TenNapel MJ; Shen X
    Am J Clin Oncol; 2019 Sep; 42(9):705-710. PubMed ID: 31368905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy.
    Moschini M; Sharma V; Dell'oglio P; Cucchiara V; Gandaglia G; Cantiello F; Zattoni F; Pellucchi F; Briganti A; Damiano R; Montorsi F; Salonia A; Colombo R
    BJU Int; 2016 Apr; 117(4):604-10. PubMed ID: 25851271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delays in radical cystectomy for muscle-invasive bladder cancer.
    Chu AT; Holt SK; Wright JL; Ramos JD; Grivas P; Yu EY; Gore JL
    Cancer; 2019 Jun; 125(12):2011-2017. PubMed ID: 30840335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.